about
Pharmaceutical care for elderly patients shared between community pharmacists and general practitioners: a randomised evaluation. RESPECT (Randomised Evaluation of Shared Prescribing for Elderly people in the Community over Time) [ISRCTN16932128]Medication-related problem type and appearance rate in ambulatory hemodialysis patientsSeniors managing multiple medications: using mixed methods to view the home care safety lensPreventing hospital admissions by reviewing medication (PHARM) in primary care: design of the cluster randomised, controlled, multi-centre PHARM-studyStrengths and weaknesses of immunotherapy for advanced non-small-cell lung cancer: a meta-analysis of 12 randomized controlled trials.Association between Total Daily Doses with duration of hospitalization among readmitted patients in a multi-ethnic Asian population.Effect of medication review and cognitive behaviour treatment by community pharmacists of patients discharged from the hospital on drug related problems and compliance: design of a randomized controlled trialRacial disparities in the quality of medication use in older adults: baseline findings from a longitudinal study.Health care use and costs of adverse drug events emerging from outpatient treatment in Germany: a modelling approach.Medication-related visits in a pediatric emergency department: an 8-years retrospective analysis.Drug-related problems among medical ward patients in Jimma university specialized hospital, Southwest Ethiopia.Safety in home care: A research protocol for studying medication management.Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review.Impact of pharmacist interventions on drug-related problems and laboratory markers in outpatients with human immunodeficiency virus infection.A systematic review of hospitalization resulting from medicine-related problems in adult patients.The contribution of a clinical pharmacist to the improvement of medication at a geriatric hospital unit in NorwayPharmaceutical care outcomes in an outpatient human immunodeficiency virus treatment center in Jos, NigeriaMedicare disease management in policy contextAn exploration of the role of pharmacists within general practice clinics: the protocol for the pharmacists in practice study (PIPS).A guided interview process to improve student pharmacists' identification of drug therapy problems.Improving the quality of clinical pharmacy services: a process to identify and capture high-value "quality actions"Effects of a pharmacist-led structured medication review in primary care on drug-related problems and hospital admission rates: a randomized controlled trialMultifaceted intervention including motivational interviewing to support medication adherence after stroke/transient ischemic attack: a randomized trial.Admissions for drug-related problems at the Emergency Department of a University Hospital in the Kingdom of Saudi ArabiaDrug-related problems in type 2 diabetes mellitus patients with dyslipidemiaA randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients.Racial disparities in quality of medication use in older adults: findings from a longitudinal study.Can pharmacists influence the health-related quality of life of patients with asthma?: The New Zealand Pharmaceutical Care experience.Epidemiology of adverse drug reactions in Europe: a review of recent observational studiesDevelopment and testing of a tool for assessing and resolving medication-related problems in older adults in an ambulatory care setting: the individualized medication assessment and planning (iMAP) tool.Pattern of drug therapy problems and interventions in ambulatory patients receiving antiretroviral therapy in Nigeria.Frequency and characteristics of hospital admissions associated with drug-related problems in paediatricsMedication reviews in the community: results of a randomized, controlled effectiveness trialAmsterdam tool for clinical medication review: development and testing of a comprehensive tool for pharmacists and general practitioners.Protocol for a Prospective (P) study to develop a model to stratify the risk (RI) of medication (M) related harm in hospitalized elderly (E) patients in the UK (The PRIME study).Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems.Safer drug use in primary care - a pilot intervention study to identify improvement needs and make agreements for change in five Swedish primary care units.Association between number of doses per day, number of medications and patient's non-compliance, and frequency of readmissions in a multi-ethnic Asian populationSupportive care in patients with advanced non-small-cell lung cancer.Do fall-risk-increasing drugs have an impact on mortality in older hip fracture patients? A population-based cohort study.
P2860
Q24798098-29150655-F4A9-4833-BAF2-BFFE9215D21AQ24805292-455C7429-57FE-42F8-99FD-7F15CAE3DF8AQ27307098-052627CF-8BE9-4976-B92D-3E145D19D6AAQ28743369-A94E951C-DFE5-4C9C-A1DE-C43A73318C01Q31050197-A7176765-B69F-497C-B19E-3948B3DDE8FFQ33431895-9F60F3CD-0323-4E03-8C69-826DF649E3FFQ33540855-0BC51BEA-A432-43C8-8A2F-76B52655C36DQ33730851-2AB124A5-91B7-42EE-BD62-4A944CAC31C9Q33792583-8FDCFA29-ED86-4EEE-8E4B-7376E9ED8AF1Q33796209-1E9F4DE3-94CD-4051-8CED-5E45DC7ACF19Q33834249-A9882DC6-0FC0-43B9-B5CA-479A66FBB3F6Q33951628-3C8E6044-C570-44B9-BAA0-21B9FCDFDFB2Q33967473-7EBED5B1-6428-428C-BB2E-757B87E254D6Q34034101-2CDC7DAD-9EF3-4D81-8213-11026E925841Q34065250-E7848A0E-C552-4DE5-B0F1-164D340B85B2Q34100728-A0B422B8-98D0-4F01-A320-8107259B5C60Q34162556-02C8FDE5-19C1-426C-9425-35962650168BQ34329000-B936537F-DDC3-4DF9-9985-9C1106D28610Q34372817-2F86685F-E93E-4B9F-AD2F-A3E2554A343AQ34628236-5DE61DAC-9D62-4814-8998-F555683D5C1EQ34646108-14ACD1A9-DB68-4BBC-8830-6EEE26D78FF3Q34781612-397FF7A3-C0D4-4558-BC8D-1D121E2A6814Q34975071-9BEC27D9-7F4E-4447-B93C-DD82E551DAA4Q35052141-89B0D0DB-EF44-403B-9D69-952209DC1ECEQ35068358-E901E33D-F322-4AD5-96BA-0BDC94089D55Q35151978-AE9C1B96-E4BD-4AD1-AB44-57FCB371086AQ35154065-93A7D5AF-4422-426C-8B26-3F2BFF896AA0Q35217273-A3696EA9-9D04-49CB-B876-3A8128D6A728Q35546999-F42568EE-5D1B-40A0-845D-713C2C84906BQ35613581-1256A7C2-730A-4A9E-ABE5-B42C7403201EQ35788546-BF12E7D1-2659-46E3-95D3-0FE68055154BQ35826144-63C823BB-89E2-4669-9AFB-FED3F33EB937Q35826551-492EC288-9415-43BF-B4DA-CCAA3DB785F8Q35832417-AB1C89D6-F562-4324-AFD6-67CBFE26E9FCQ35898547-EA3FE2C3-DB68-4F37-A194-652BB97A6572Q36024341-5816A9B0-E68C-41A9-91F1-666EF1A43F4CQ36156800-CA46EB28-2A00-49F9-984B-62B851FB1DFDQ36486834-2CBA1FB5-C071-49D7-83D9-3C225CADD271Q36648391-F82FC354-A571-45CE-BE54-10099FA36543Q36872736-8FF71C86-846F-475B-95FB-E8AF19A0023E
P2860
description
1990 nî lūn-bûn
@nan
1990 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Drug-related problems: their structure and function.
@ast
Drug-related problems: their structure and function.
@en
Drug-related problems: their structure and function.
@nl
type
label
Drug-related problems: their structure and function.
@ast
Drug-related problems: their structure and function.
@en
Drug-related problems: their structure and function.
@nl
prefLabel
Drug-related problems: their structure and function.
@ast
Drug-related problems: their structure and function.
@en
Drug-related problems: their structure and function.
@nl
P2093
P1476
Drug-related problems: their structure and function.
@en
P2093
P304
P577
1990-11-01T00:00:00Z